Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)

AUTOR(ES)

Ni, Y. G.

FONTE

The National Academy of Sciences of the USA

RESUMO

To determine if N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), a carboxyl group activating agent, can inactivate 5HT2c receptors, we have examined the effects of EEDQ on 5HT2c receptor-mediated responses to 5-hydroxytryptamine (5HT) in Xenopus oocytes, and on the binding of [3H]5HT to 5HT2c receptors in transfected HeLa cells. In oocytes expressing rat 5HT2c receptors, EEDQ inhibited the 5HT2c receptor-mediated Cl− currents; and the response did not recover more than 24 h after removal of the EEDQ. To see if this effect of EEDQ was on the receptor itself, the binding of 5HT to 5HT2c receptors was studied in transfected HeLa cells. EEDQ decreased the specific binding of [3H]5HT to 5HT2c receptors. At ≈22°C, incubating the membranes with 2 × 10−4 M EEDQ for 1 h caused a 40% decrease in the Bmax, without changing the Kd. At 37°C, the same treatment with EEDQ blocked [3H]5HT binding completely. Half-maximal inhibition occurred at 5 μM EEDQ at both temperatures, and washing for 1.5 h did not restore the binding, suggesting that the inactivation of 5HT2c receptor binding was practically irreversible. Results from both systems showed clearly that EEDQ is an irreversible antagonist of 5HT2c receptors and therefore can be used for many studies of this receptor.

Documentos Relacionados

• Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac)
• Serotonin inhibits Ca2+ currents in porcine melanotrophs by activating 5-HT1C and 5-HT1A receptors.
• The therapeutic role of 5-HT1A and 5-HT2A receptors in depression
• Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension
• Synaptic multiprotein complexes associated with5-HT2C receptors: a proteomic approach